Det anbefales, at hæmoglobin og/ eller hæmatokrit måles undervejs i behandlingen med Volibris, fx efter 1 måned, 3 måneder og derefter periodisk iht. klinisk praksis.
It is recommended that haemoglobin and/ or haematocrit levels are measured during treatment with Volibris, for example at 1 month, 3 months and periodically thereafter in line with clinical practice.